Search results
Found 8 matches for
The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.
National clinical study launched to test new technologies for detecting liver cancer
25 May 2022
The SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.
Dairy products linked to increased risk of cancer
6 May 2022
The first major study to investigate dairy consumption and cancer risk in Chinese adults found that greater intake was associated with higher risks of liver cancer and female breast cancer.
First major UK prospective study for liver cancer underway
24 February 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
Changing drinking patterns in China could drive a major increase in liver diseases
19 September 2021
According to new research led by NDPH, Chinese people who regularly drink alcohol have significantly greater risks of developing severe liver diseases, such as cancer.
DeLIVER clinical research study underway as recruitment opens
23 March 2021
The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.
Studying viral genetics to aid liver cancer early detection
15 February 2021
Professor Ellie Barnes and Dr Azim Ansari receive funding to identify cancer-associated strains of hepatitis C in Pakistan to improve assessment of liver cancer risk.
Investigating the effects of co-morbidities on liver cancer risk
13 December 2020
Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.
Prof. Ellie Barnes comments on the 2020 Nobel Prize for Medicine
7 October 2020
Prof Ellie Barnes comments on the recent Nobel Prize in Medicine, awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of the Hepatitis C virus, a major global health problem and a cause of cancer